Skip to Content
  • Previous Rank
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees
  • Market Value — as of March 29, 2018 ($M)

In 2017, pharmacy benefits giant Express Scripts saw its net income skyrocket by 33% year-over-year to $4.51 billion. But a healthy chunk of that income — $1.38 billion — was attributable to the tax law signed by President Donald Trump late last year. While Scripts touted investments in its workforce as a result of the corporate tax cut, it also repurchased 45.9 million of its shares in a stock buyback of nearly $2.95 billion. In 2018, the company will be sure to keep an eye on potential pushback on benefits managers at large, which some critics say contribute to high drug prices because of the industry’s convoluted drug rebate structure. Express Scripts is also in the midst of a proposed $54 billion megadeal to be purchased by insurer Cigna.

Company Info

Timothy C. Wentworth
CEO Title
President, Chief Executive Officer & Director
Health Care
Health Care: Pharmacy and Other Services
HQ Location
St. Louis
Years on Fortune 500 List19

Express Scripts Holding Rank History


Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$100,064.60-0.2%
Profits ($M)$4,517.4032.7%
Assets ($M)$54,255.80-
Total Stockholder Equity ($M)$18,119.60-
Market Value — as of March 29, 2018 ($M)$38,790.60-

Profit Ratios

Profit as % of Revenues4.5%
Profits as % of Assets8.3%
Profits as % of Stockholder Equity24.9%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)7.74
EPS % Change (from 2016)43.6%
EPS % Change (5 year annual rate)34.5%
EPS % Change (10 year annual rate)21.8%

Total Return

Total Return to Investors (2017)8.5%
Total Return to Investors (5 year, annualized)6.7%
Total Return to Investors (10 year, annualized)7.4%